NCT05995743View on ClinicalTrials.gov

VO2max & HRQoL in Children With Sickle Cell Disease

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

November 1, 2022

Study Completion Date

November 1, 2022

Conditions
Sickle CellChildren
Trial Locations (1)

34295

Pediatric and Congenital Cardiology Department, Arnaud De Villeneuve University Hospital, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT05995743 - VO2max & HRQoL in Children With Sickle Cell Disease | Biotech Hunter | Biotech Hunter